JP Morgan Healthcare Week

  • January 8, 2024 - January 11, 2024
  • San Francisco, CA

Biomica CEO, Dr. Elran Haber, will be in San Francisco for the JPMorgan Healthcare week. If you are attending and would like to meet email Rachel Pomerantz Gerber, Head of Investor Relations at Evogene, at rachel.pomerantz@evogene.com.

 

Back to all News

Highlighted News About Biomica

May 23, 2024

Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based Therapeutic, BMC128, for Refractory RCC, NSCLC & Melanoma

Preliminary Phase 1 results show promising trends for BMC128 in combination with nivolumab in refractory cancer patients. Data will be showcased at the 2024 American Society of Clinical Oncology (ASCO) annual meeting REHOVOT, Israel, May 23, 2024. Biomica Ltd., a clinical-stage biopharmaceutical company developing innovative microbiome-based therapeutics and a subsidiary of Evogene Ltd. (Nasdaq: EVGN, TASE: […]